Serum Bilirubin Levels and Cardiovascular Disease Risk
- 29 April 2010
- book chapter
- review article
- Published by Elsevier BV in Advances in Clinical Chemistry
- Vol. 50, 47-63
- https://doi.org/10.1016/s0065-2423(10)50003-9
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels—The Framingham Heart StudyAtherosclerosis, 2009
- Genome-wide association meta-analysis for total serum bilirubin levelsHuman Molecular Genetics, 2009
- Bilirubin and glutathione have complementary antioxidant and cytoprotective rolesProceedings of the National Academy of Sciences of the United States of America, 2009
- Serum Total Bilirubin Level, Prevalent Stroke, and Stroke Outcomes: NHANES 1999–2004The American Journal of Medicine, 2008
- The paradoxical relationship between serum uric acid and cardiovascular diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- ‘‘Iatrogenic Gilbert syndrome’’– A strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubinMedical Hypotheses, 2007
- High Serum Bilirubin Concentrations Preserve Coronary Flow Reserve and Coronary Microvascular FunctionsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levelsAtherosclerosis, 2002
- Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than troloxLife Sciences, 1994
- Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989